Other Information.
−Removed: On June 1, 2023, Sean McCarthy, Chief Executive Officer and Chairman, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 109,768 shares of the Company’s common stock between January 1, 2024 and February 7, 2025.
CytomX Therapeutics, Inc.
8 unchanged sentences
Form of Tranche Warrant
−Removed: Amendment No.
−Removed: 3 to the Collaboration and License Agreement, dated as of May 18, 2023, by and between CytomX Therapeutics, Inc.
−Removed: and Amgen, Inc.
−Removed: Form of Amended and Restated Severance and Change of Control Agreement by and between CytomX Therapeutics, Inc.
−Removed: and each of its executive officers other than Sean A.
−Removed: Employment Offer Letter Agreement between CytomX Therapeutics, Inc.
−Removed: and Jeffrey Landau dated as of March 31, 2021.
−Removed: Unit Purchase Agreement by and among the CytomX Therapeutics, Inc.
−Removed: and certain accredited investors named therein, dated June 29, 2023.
+Added: Transition Agreement effective as of August 22, 2023 by and between CytomX Therapeutics, Inc., and AbbVie Global Enterprises Ltd.
Certification of Chief Executive Principal required by Rule 13a-14(a) or Rule 15d-14(a).
8 unchanged sentences
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
−Removed: CytomX Therapeutics, Inc.
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
Certain confidential portions of this exhibit have been omitted from this exhibit.
−Removed: # Indicates management contract or compensatory plan.
* The certifications attached as Exhibit 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are not deemed filed with the SEC and are not to be incorporated by reference into any filing of CytomX Therapeutics, Inc.
3 unchanged sentences
CytomX Therapeutics, Inc.
−Removed: August 8, 2023
+Added: November 7, 2023
Chief Executive Officer and Chairman
(Principal Executive Officer)
−Removed: August 8, 2023
+Added: November 7, 2023
/s/ Christopher W.
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.